Highlights
NASDAQ: MDGL       Madrigal Pharmaceuticals Inc
Last Price Today's Change   Day's Range   Trading Volume
192.48   -6.49 (3.26%)  190.11 - 205.98  149,600

Overview

 
Avg Volume (4 weeks):182,426
4 Weeks Range:182.01 - 232.40
4 Weeks Price Volatility (%):
20.78%
52 Weeks Range:38.82 - 325.98
52 Weeks Price Volatility (%):
53.51%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed ß-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. In addition, MGL-3196 also reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action. Geographically, all the business activity is functioned through the US.

  Be the first to like this.
 


 

2759  4994  739  220 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 SPY 276.25-0.15 
 AMD 23.66-2.96 
 GE 12.56+0.18 
 QQQ 173.02-0.16 
 EEM 39.67+0.37 
 XLF 26.67+0.10 
 VXX 34.05-0.60 
 BAC 28.32+0.07 
 F 8.50-0.01 
 TTNP 0.378+0.057 
Partners & Brokers